Treace Medical Concepts Stock Performance
| TMCI Stock | USD 5.65 0.14 2.42% |
The entity has a beta of 1.47, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Treace Medical will likely underperform. At this point, Treace Medical Concepts has a negative expected return of -0.17%. Please make sure to validate Treace Medical's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Treace Medical Concepts performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Treace Medical Concepts has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's fundamental indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (2.42) | Five Day Return (5.83) | Year To Date Return (28.21) | Ten Year Return (77.87) | All Time Return (77.87) |
1 | TMCIRosen Law Firm10Treace Medical Concepts, Inc. | 06/02/2025 |
2 | DEADLINE ALERT for TMCI, IBTA, NPWR Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions | 06/05/2025 |
3 | TMCI INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Treace Medical ... | 06/10/2025 |
4 | SHAREHOLDER ALERT Morris Kandinov Investigating VIRT, NSSC, DV, and TMCI Shareholders are Encouraged to Contact the Firm | 06/18/2025 |
5 | Disposition of 5021 shares by John Treace of Treace Medical subject to Rule 16b-3 | 06/20/2025 |
6 | Notice to Long-Term Shareholders of MicroStrategy, Inc. - GlobeNewswire | 06/27/2025 |
7 | Important Notice to Long-Term Shareholders of Centene Corporation DoubleVerify Holdings, Inc. Napco Security Technologies, Inc, and Treace Medical Concepts, Inc... | 07/18/2025 |
| Begin Period Cash Flow | 13 M |
Treace Medical Relative Risk vs. Return Landscape
If you would invest 644.00 in Treace Medical Concepts on April 20, 2025 and sell it today you would lose (79.00) from holding Treace Medical Concepts or give up 12.27% of portfolio value over 90 days. Treace Medical Concepts is currently does not generate positive expected returns and assumes 3.0119% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Treace, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Treace Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Treace Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Treace Medical Concepts, and traders can use it to determine the average amount a Treace Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.055
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TMCI |
Estimated Market Risk
| 3.01 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Treace Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Treace Medical by adding Treace Medical to a well-diversified portfolio.
Treace Medical Fundamentals Growth
Treace Stock prices reflect investors' perceptions of the future prospects and financial health of Treace Medical, and Treace Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Treace Stock performance.
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.25) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 357.49 M | ||||
| Shares Outstanding | 62.91 M | ||||
| Price To Book | 3.46 X | ||||
| Price To Sales | 1.75 X | ||||
| Revenue | 209.36 M | ||||
| Gross Profit | 169.18 M | ||||
| EBITDA | (42.07 M) | ||||
| Net Income | (55.74 M) | ||||
| Cash And Equivalents | 101.53 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 69.65 M | ||||
| Debt To Equity | 0.99 % | ||||
| Current Ratio | 8.13 X | ||||
| Book Value Per Share | 1.68 X | ||||
| Cash Flow From Operations | (37.17 M) | ||||
| Earnings Per Share | (0.85) X | ||||
| Market Capitalization | 364.22 M | ||||
| Total Asset | 217.09 M | ||||
| Retained Earnings | (189.99 M) | ||||
| Working Capital | 126.48 M | ||||
About Treace Medical Performance
By evaluating Treace Medical's fundamental ratios, stakeholders can gain valuable insights into Treace Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Treace Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Treace Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 348.67 | 215.95 | |
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.31) | (0.32) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (0.49) | (0.52) |
Things to note about Treace Medical Concepts performance evaluation
Checking the ongoing alerts about Treace Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Treace Medical Concepts help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Treace Medical generated a negative expected return over the last 90 days | |
| Treace Medical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 209.36 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 169.18 M. | |
| Treace Medical Concepts currently holds about 101.53 M in cash with (37.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Treace Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Important Notice to Long-Term Shareholders of Centene Corporation DoubleVerify Holdings, Inc. Napco Security Technologies, Inc, and Treace Medical Concepts, Inc. Grabar Law Office is Investigating Claims on Your Behalf |
- Analyzing Treace Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Treace Medical's stock is overvalued or undervalued compared to its peers.
- Examining Treace Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Treace Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Treace Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Treace Medical's stock. These opinions can provide insight into Treace Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |